This trial is active, not recruiting.

Condition lung cancer
Sponsor Ottawa Hospital Research Institute
Start date June 2012
End date August 2017
Trial size 37 participants
Trial identifier NCT01799980, 2009471-01H


This study will compare two different methods of staging lung cancer to determine whether endobronchial ultrasound (EBUS) staging of mediastinal lymph nodes will provide good diagnostic yield in detecting lung cancer, when compared to current methods of a staging bronchoscopy and cervical mediastinoscopy.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
This group will undergo cervical mediastinoscopy before surgery to stage their lung cancer (procedure decided by the surgeon).
This group will undergo endobronchial ultrasound before surgery to stage their lung cancer (procedure decided by the surgeon).

Primary Outcomes

Lung cancer staging
time frame: Pre-op and post-op

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: Patients, > 18 years of age, Gender- Males and Female Diagnosis of Non Small Cell Lung Cancer. Patients who have consented on an Ottawa Hospital consent form to undergo a mediastinoscopy procedure or EBUS-TBNA, and a Positron emission tomography (PET) of the chest for lung cancer staging. Exclusion Criteria: Females who are pregnant (or found to be pregnant) during the course of this research study. Patients who do not provide their Ottawa Hospital consent to undergo a staging bronchoscopy , cervical mediastinoscopy or EBUS-TBNA.

Additional Information

Official title Evaluation of Endobronchial Ultrasound (EBUS) for Staging Lung Cancer
Principal investigator Donna E Maziak, MD, MSc
Trial information was received from ClinicalTrials.gov and was last updated in August 2016.
Information provided to ClinicalTrials.gov by Ottawa Hospital Research Institute.